Cell Signaling Technology

PP2A B Subunit Antibody

#4953 · western blot · $136,317

64
Evidence Score · Well-Established
Used by 287 independent labs across 301 papers. How we score this →
100
Citing papers
8k
Combined citations
Supplier page Find this product

Research areas

Cell death mechanisms and regulation8Lung Cancer Treatments and Mutations8Epigenetics and DNA Methylation8Ubiquitin and proteasome pathways6NF-κB Signaling Pathways6Liver physiology and pathology6Microtubule and mitosis dynamics6Chemokine receptors and signaling5

Papers citing this product

1
Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
Scientific Reports·2017·453 cit.·DOI
2
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer
Nature Communications·2017·409 cit.·DOI
3
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
ACS Chemical Biology·2015·290 cit.·DOI
4
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
Nature Communications·2015·258 cit.·DOI
5
A Novel Secreted Protein, MYR1, Is Central to <i>Toxoplasma</i> ’s Manipulation of Host Cells
mBio·2016·187 cit.·DOI
6
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond
Drug Design Development and Therapy·2011·182 cit.·DOI
7
Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model
Pharmaceutics·2020·172 cit.·DOI
8
Proteasome Inhibition Sensitizes Hepatocellular Carcinoma Cells, But Not Human Hepatocytes, to TRAIL *
Hepatology·2005·171 cit.·DOI
9
Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis
Frontiers in Pharmacology·2018·169 cit.·DOI
10
The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells
Cancer Research·2007·164 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
PP2A B Subunit (2G9) Mouse Monoclonal AntibodyMouseCell Signaling Technology64$147,345100
PP2A B Subunit (100C1) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology64$148,348100

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.